The safety of anti PD-1 therapeutics for the treatment of melanoma-Reference-Cited by-同舟云学术

The safety of anti PD-1 therapeutics for the treatment of melanoma

Published:2016-10-24 Issue:1 Volume:16 Page:41-53
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Ramelyte Egle¹²,Schindler Sabrina A.¹,Dummer Reinhard¹

Affiliation:

1. Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

2. Centre of Dermatovenereology, Vilnius University Hospital Santariskiu klinikos, Vilnius, Lithuania

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2016.1248402

Reference99 articles.

1. American Cancer Society. Skin cancer facts and figures. J Clin Oncol. 2008 Feb 1;26(4):527-34. Available from: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf

2. Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

3. Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684.

4. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Imaging of Melanoma VEGF-expressing Tumors through [^99mTc]Tc-HYNIC-Fab(Bevacizumab);Anti-Cancer Agents in Medicinal Chemistry;2024-11

2. Unveiling the Role of Tryptophan 2,3-Dioxygenase in the Angiogenic Process;Pharmaceuticals;2024-04-27

3. Plasmid co-expressing siRNA-PD-1 and Endostatin carried by attenuated Salmonella enhanced the anti-melanoma effect via inhibiting the expression of PD-1 and VEGF on tumor-bearing mice;International Immunopharmacology;2024-01

4. The role of angiogenesis in melanoma: Clinical treatments and future expectations;Frontiers in Pharmacology;2022-12-15

5. Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanoma;Journal of Cancer Research and Clinical Oncology;2022-09-11